Home >  Diabetes and Endocrinology >  Diabetes and Endocrinology News >  Latest Triple Combination...

Latest Triple Combination of Empagliflozin, Sitagliptin and Metformin for Advanced Care in Indian T2DM Patients - When to Consider?

Written By :  Dr. Nandita Mohan
Published On 2026-01-03 05:45 GMT   |   Update On 2026-01-03 07:02 GMT
Advertisement

In this episode of The Diabetes Wellness Forum, titled "Importance of Early Aggressive Glucose Control-Approach in 2025," Dr Nandita Mohan from Medical Dialogues is in conversation with Dr Vaishali Deshmukh, Consultant Diabetologist & Endocrinologist at Deenanath Mangeshkar Hospital, Pune, Maharashtra and Dr Altamash Shaikh, Consultant Endocrinologist & Diabetologist and Metabolic Physician, Saifee Hospital, Mumbai, Maharashtra, to discuss a critical aspect of diabetes care in 2025.

Advertisement

With Type 2 diabetes increasingly affecting younger individuals in India and showing rapid disease progression, early and effective glucose control has become essential to prevent long-term microvascular and macrovascular complications. It highlights real-world strategies and contemporary approaches to early aggressive glucose management in 2025.

During this episode, the experts address three key clinical questions:

1. What is the burden of uncontrolled Type 2 diabetes and the major clinical challenges in managing these patients?

2. What is the clinical utility of the empagliflozin, sitagliptin, and metformin combination in uncontrolled Type 2 diabetes?

3. Which patient profiles are best suited for empagliflozin, sitagliptin, and metformin fixed-dose combination therapy?


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Poor Glycemic Control in Type 1 Diabetes Associated with Increased CKD: Study

Osteoporosis Linked to Dementia Risk: Evidence from a Chinese Cohort Study

Millet-Based Diets may improve Metabolic Health in Type 2 Diabetes Patients, suggests study

Researchers Find Stress Raises Blood Sugar, Especially in Insulin-Resistant Individuals

Preoperative Calcium Supplements May Improve Post-Thyroidectomy Outcomes in Patients with Graves's Disease: Study

Daily Stress Raises Blood Glucose Especially in Insulin-Resistant Individuals: Study

LDL-C Oxidation Linked to Plaque Vulnerability in Diabetes: Study Shows